312 related articles for article (PubMed ID: 28625372)
1. Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol.
Kutyifa V; Beck C; Brown MW; Cannom D; Daubert J; Estes M; Greenberg H; Goldenberg I; Hammes S; Huang D; Klein H; Knops R; Kosiborod M; Poole J; Schuger C; Singh JP; Solomon S; Wilber D; Zareba W; Moss AJ;
Am Heart J; 2017 Jul; 189():158-166. PubMed ID: 28625372
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of outcome of Indian patients who meet MADIT II (Multicenter Automatic Defibrillator Implantation Trial) criteria for implantable cardioverter defibrillator implantation: is it appropriate for Indian patients?
Yadav R; Chandra A; Yadav G; Naik N
Indian Heart J; 2020; 72(3):172-178. PubMed ID: 32768016
[TBL] [Abstract][Full Text] [Related]
3. [The impact of the Multicenter Automatic Defibrillator Implantation Trial II in a university hospital--do all patients with myocardial infarction and reduced left ventricular function need an implantable cardioverter-defibrillator?].
Lercher P; Rotman B; Scherr D; Kraxner W; Luha O; Klein W
Wien Klin Wochenschr; 2003 Mar; 115(5-6):167-74. PubMed ID: 12741076
[TBL] [Abstract][Full Text] [Related]
4. The implantable cardioverter defibrillator and primary prevention of sudden death: the Multicenter Automatic Defibrillator Implantation Trial and the Coronary Artery Bypass Graft (CABG)-Patch Trial.
Block M; Breithardt G
Am J Cardiol; 1999 Mar; 83(5B):74D-78D. PubMed ID: 10089844
[TBL] [Abstract][Full Text] [Related]
5. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials?
Coats AJ
Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150
[TBL] [Abstract][Full Text] [Related]
6. Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes.
Sharma A; Al-Khatib SM; Ezekowitz JA; Cooper LB; Fordyce CB; Michael Felker G; Bardy GH; Poole JE; Thomas Bigger J; Buxton AE; Moss AJ; Friedman DJ; Lee KL; Steinman R; Dorian P; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Peterson ED; Inoue LYT; Sanders GD
Eur J Heart Fail; 2018 Jun; 20(6):1031-1038. PubMed ID: 29761861
[TBL] [Abstract][Full Text] [Related]
7. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.
Choy B; Hansen E; Moss AJ; McNitt S; Zareba W; Goldenberg I;
Am J Cardiol; 2010 Mar; 105(5):581-6. PubMed ID: 20185000
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
[TBL] [Abstract][Full Text] [Related]
9. Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.
Winther-Jensen M; Kjaergaard J; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Kragholm K; Christensen EF; Hassager C
Eur Heart J Acute Cardiovasc Care; 2017 Mar; 6(2):144-154. PubMed ID: 28058848
[TBL] [Abstract][Full Text] [Related]
10. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
Zareba W; Piotrowicz K; McNitt S; Moss AJ;
Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
[TBL] [Abstract][Full Text] [Related]
11. Failure to reassess ejection fraction after acute myocardial infarction in potential implantable cardioverter/defibrillator candidates: insights from the Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients' Health Status (TRIUMPH) registry.
Miller AL; Gosch K; Daugherty SL; Rathore S; Peterson PN; Peterson ED; Ho PM; Chan PS; Lanfear DE; Spertus JA; Wang TY
Am Heart J; 2013 Oct; 166(4):737-43. PubMed ID: 24093855
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic implantable cardioverter defibrillator trials: MUSTT, MADIT, and beyond. Multicenter Unsustained Tachycardia Trial. Multicenter Automatic Defibrillator Implantation Trial.
Prystowsky EN; Nisam S
Am J Cardiol; 2000 Dec; 86(11):1214-5, A5. PubMed ID: 11090794
[TBL] [Abstract][Full Text] [Related]
13. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II).
Greenberg H; Case RB; Moss AJ; Brown MW; Carroll ER; Andrews ML;
J Am Coll Cardiol; 2004 Apr; 43(8):1459-65. PubMed ID: 15093884
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results.
Gold MR; Aasbo JD; El-Chami MF; Niebauer M; Herre J; Prutkin JM; Knight BP; Kutalek S; Hsu K; Weiss R; Bass E; Husby M; Stivland TM; Burke MC
Heart Rhythm; 2017 Oct; 14(10):1456-1463. PubMed ID: 28502872
[TBL] [Abstract][Full Text] [Related]
15. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.
Huang DT; Sesselberg HW; McNitt S; Noyes K; Andrews ML; Hall WJ; Dick A; Daubert JP; Zareba W; Moss AJ;
J Cardiovasc Electrophysiol; 2007 Aug; 18(8):833-8. PubMed ID: 17537209
[TBL] [Abstract][Full Text] [Related]
16. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
Goldenberg I; Moss AJ; McNitt S; Zareba W; Hall WJ; Andrews ML; Wilber DJ; Klein HU;
J Am Coll Cardiol; 2006 May; 47(9):1811-7. PubMed ID: 16682305
[TBL] [Abstract][Full Text] [Related]
17. Effect of elapsed time from coronary revascularization to implantation of a cardioverter defibrillator on long-term survival in the MADIT-II trial.
Barsheshet A; Goldenberg I; Moss AJ; Huang DT; Zareba W; McNitt S; Klein HU; Guetta V
J Cardiovasc Electrophysiol; 2011 Nov; 22(11):1237-42. PubMed ID: 21615813
[TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter-defibrillators: a new preventive medical option.
Glatter KA; Young JN; McElvany MD
Prev Cardiol; 2006; 9(1):49-53; quiz 54-5. PubMed ID: 16407703
[TBL] [Abstract][Full Text] [Related]
19. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
Bloomfield DM; Steinman RC; Namerow PB; Parides M; Davidenko J; Kaufman ES; Shinn T; Curtis A; Fontaine J; Holmes D; Russo A; Tang C; Bigger JT
Circulation; 2004 Oct; 110(14):1885-9. PubMed ID: 15451804
[TBL] [Abstract][Full Text] [Related]
20. Defibrillator implantations for primary prevention in the United States: Inappropriate care or inadequate documentation: Insights from the National Cardiovascular Data ICD Registry.
Kaiser DW; Tsai V; Heidenreich PA; Goldstein MK; Wang Y; Curtis J; Turakhia MP;
Heart Rhythm; 2015 Oct; 12(10):2086-93. PubMed ID: 25982720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
